ABC NewsDoug Melton of the Harvard Stem Cell Institute, who was not involved with the work, called the paper an impressive technical achievement. But he said he believed the cells would be useful as a research tool rather than a source of transplants. They …First Stem Cells Cloned From Diabetes Patient, Thanks to Egg DonorsTIMECloning … Continue reading
TIMEIs donating eggs to scientists for a research study any different from donating eggs to a couple hoping to have a baby using in vitro fertilization (IVF)? That’s a question that stem cell researchers — and policy makers — have been wrestling with …Cloning approach makes diabetes stem cell advanceThe StateCloning Cells for Diabetes TreatmentsMIT … Continue reading
National GeographicPublished April 28, 2014. Regenerative medicine took a step forward on Monday with the announcement of the creation of the first disease-specific line of embryonic stem cells made with a patient’s own DNA. These cells, which used DNA from a 32-year-old …Cloning Approach Makes Diabetes Stem Cell AdvanceABC NewsStem Cells Made From Cloning Diabetic … Continue reading
Cloning Cells for Diabetes TreatmentsMIT Technology ReviewIn January 2013, researchers at the Oregon Health and Science University reported that they had successfully created embryonic stem cells from a human embryo formed when the nucleus of one person’s cell was transferred into another person’s egg that … …read more &nbs… Continue reading
Phys.OrgAs reported today in Nature, the scientists derived embryonic stem cells by adding the nuclei of adult skin cells to unfertilized donor oocytes using a process called somatic cell nuclear transfer (SCNT). Embryonic stem cells were created from one …Stem cells made from adult skin cellsDigitalJournal.com all 2 news articles …read more &nbs… Continue reading
Phase 2 Stem Cell Study for ALS ApprovedMonthly Prescribing ReferenceBrain Storm Cell Therapeutics announced that the Phase 2 clinical trial of NurOwn for patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease, has received FDA approval to begin. NurOwn is an autologous, adult stem cell … and more …read more &nbs… Continue reading
Crain’s Cleveland BusinessThe results reflect patient data for eight weeks following cell therapy or placebo administration, Athersys said. Additional 16-week results, including data about the impact from a second round of dosing for a subset of patients, will be available …Athersys stem–cell therapy for bowel disease fails in studyReutersAthersys stem cell therapy disappoints in first … Continue reading
UPDATE 1-Athersys stem–cell therapy for bowel disease fails in trialReutersThe stem–cell therapy, known as MultiStem, is derived from adult bone marrow or other tissue sources and is designed to reduce inflammation and protect and heal damaged tissue. MultiStem was being tested in patients with ulcerative colitis who have …Athersys Inc. stem cell therapy for bowel … Continue reading